Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Natural Product Reports | journal | 3.020 Q1 | 211 | 83 | 210 | 13863 | 1692 | 201 | 7.76 | 167.02 | |
2 | Critical Reviews in Toxicology | journal | 1.546 Q1 | 129 | 43 | 114 | 5878 | 625 | 106 | 4.84 | 136.70 | |
3 | RSC Drug Discovery Series | book series | 13 | 28 | 0 | 3295 | 0 | 0 | 0.00 | 117.68 | ||
4 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 | |
5 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
6 | Expert Opinion on Drug Delivery | journal | 1.546 Q1 | 133 | 97 | 253 | 9623 | 1281 | 242 | 5.11 | 99.21 | |
7 | Toxin Reviews | journal | 0.258 Q3 | 54 | 11 | 67 | 966 | 69 | 64 | 1.08 | 87.82 | |
8 | Expert Opinion on Biological Therapy | journal | 1.256 Q1 | 102 | 147 | 477 | 12860 | 1755 | 468 | 3.73 | 87.48 | |
9 | Expert Review of Clinical Pharmacology | journal | 0.218 Q2 | 60 | 68 | 129 | 5932 | 95 | 110 | 0.74 | 87.24 | |
10 | Expert Opinion on Drug Discovery | journal | 0.548 Q2 | 84 | 90 | 330 | 7820 | 539 | 322 | 1.55 | 86.89 | |
11 | HIV Therapy | journal | 0.260 Q3 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | |
12 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.043 Q1 | 100 | 121 | 315 | 10240 | 1249 | 310 | 3.82 | 84.63 | |
13 | CNS Neuroscience and Therapeutics | journal | 1.013 Q2 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
14 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.438 Q1 | 99 | 27 | 70 | 2257 | 349 | 66 | 4.91 | 83.59 | |
15 | Expert Opinion on Therapeutic Patents | journal | 0.687 Q2 | 88 | 118 | 324 | 9662 | 668 | 316 | 2.63 | 81.88 | |
16 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
17 | EPMA Journal | journal | 52 | 57 | 0 | 4343 | 0 | 0 | 0.00 | 76.19 | ||
18 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
19 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 | |
20 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 7 | 4 | 518 | 0 | 4 | 0.00 | 74.00 | ||
21 | Trends in Pharmacological Sciences | journal | 5.544 Q1 | 244 | 80 | 260 | 5902 | 3056 | 246 | 11.90 | 73.78 | |
22 | Future Medicinal Chemistry | journal | 0.476 Q2 | 90 | 140 | 120 | 10130 | 128 | 89 | 1.07 | 72.36 | |
23 | Therapeutic Delivery | journal | 63 | 70 | 0 | 5019 | 0 | 0 | 0.00 | 71.70 | ||
24 | Current Opinion in Drug Discovery and Development | journal | 1.661 Q1 | 85 | 68 | 221 | 4845 | 1124 | 204 | 5.31 | 71.25 | |
25 | Current Opinion in Investigational Drugs | journal | 1.257 Q1 | 83 | 144 | 375 | 10224 | 1330 | 340 | 3.70 | 71.00 | |
26 | Expert Opinion on Pharmacotherapy | journal | 0.660 Q2 | 93 | 282 | 839 | 19205 | 2183 | 815 | 2.68 | 68.10 | |
27 | Neuropsychopharmacology | journal | 3.368 Q1 | 249 | 249 | 805 | 16794 | 5537 | 779 | 6.87 | 67.45 | |
28 | Current Opinion in Molecular Therapeutics | journal | 1.336 Q1 | 67 | 88 | 220 | 5913 | 801 | 203 | 3.88 | 67.19 | |
29 | Issues in Toxicology | book series | 0.190 Q3 | 18 | 36 | 69 | 2414 | 32 | 64 | 0.65 | 67.06 | |
30 | Therapeutic Advances in Neurological Disorders | journal | 0.339 Q3 | 68 | 33 | 51 | 2177 | 45 | 44 | 0.88 | 65.97 | |
31 | BioDrugs | journal | 1.664 Q1 | 79 | 47 | 119 | 2941 | 576 | 111 | 5.36 | 62.57 | |
32 | Biomarkers in Medicine | journal | 0.326 Q3 | 56 | 95 | 120 | 5641 | 122 | 92 | 1.02 | 59.38 | |
33 | Particle and Fibre Toxicology | journal | 2.097 Q1 | 119 | 41 | 64 | 2370 | 423 | 60 | 5.58 | 57.80 | |
34 | Drug Discovery Today | journal | 2.028 Q1 | 215 | 140 | 452 | 8078 | 3126 | 428 | 6.55 | 57.70 | |
35 | Neuropharmacology | journal | 2.355 Q1 | 191 | 225 | 821 | 12830 | 3992 | 813 | 5.12 | 57.02 | |
36 | Cardiovascular Therapeutics | journal | 0.996 Q2 | 54 | 59 | 69 | 3319 | 171 | 63 | 2.48 | 56.25 | |
37 | International Journal of Neuropsychopharmacology | journal | 1.892 Q1 | 125 | 125 | 335 | 6482 | 1459 | 309 | 4.11 | 51.86 | |
38 | Drug Discovery Today: Disease Mechanisms | journal | 0.317 Q3 | 28 | 31 | 89 | 1578 | 79 | 78 | 0.87 | 50.90 | |
39 | Tetrahedron | journal | 1.526 Q1 | 236 | 1187 | 3954 | 59908 | 12586 | 3926 | 3.08 | 50.47 | |
40 | Nanotoxicology | journal | 1.501 Q1 | 107 | 32 | 85 | 1602 | 429 | 82 | 3.54 | 50.06 | |
41 | Fundamental and Clinical Pharmacology | journal | 0.642 Q2 | 85 | 86 | 257 | 4128 | 574 | 248 | 2.28 | 48.00 | |
42 | Protein and Cell | journal | 94 | 134 | 0 | 6271 | 0 | 0 | 0.00 | 46.80 | ||
43 | Toxicological Sciences | journal | 1.874 Q1 | 207 | 262 | 908 | 12241 | 4658 | 854 | 4.86 | 46.72 | |
44 | Toxicon | journal | 0.872 Q2 | 144 | 358 | 762 | 16668 | 2104 | 751 | 2.50 | 46.56 | |
45 | Journal of Applied Toxicology | journal | 0.740 Q2 | 103 | 93 | 286 | 4305 | 726 | 281 | 2.52 | 46.29 | |
46 | SAR and QSAR in Environmental Research | journal | 0.435 Q3 | 54 | 44 | 132 | 2032 | 311 | 129 | 2.18 | 46.18 | |
47 | Environmental Pollution | journal | 2.002 Q1 | 301 | 475 | 1436 | 21905 | 5928 | 1415 | 3.71 | 46.12 | |
48 | ChemMedChem | journal | 1.294 Q1 | 119 | 211 | 603 | 9609 | 2141 | 592 | 3.38 | 45.54 | |
49 | Toxicology Mechanisms and Methods | journal | 0.278 Q3 | 55 | 74 | 230 | 3336 | 243 | 224 | 1.10 | 45.08 | |
50 | Journal of Drug Targeting | journal | 1.152 Q1 | 107 | 83 | 246 | 3686 | 830 | 237 | 2.73 | 44.41 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®